Ever wondered why some iOS mobile apps cost as much as a Manhattan luxury apartment while others are built for the price of a used sedan? The truth is simple and straightforward: app pricing is not a ...

Feb 18 (Reuters) - Unnatural Products said on Wednesday it has signed a licensing agreement with Novartis (NOVN.S), opens new tab to develop macrocyclic peptide-based therapies for a cardiovascular ...

Apple has taken a small step toward securing cross-platform messaging, with early RCS encryption support now appearing in the iOS 26.4 beta. Just don't expect to get that much testing done right now.

BRISBANE, Australia & BOSTON--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that it has entered ...

Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing Pfizer (PFE.N), opens new tab access to its technology that boosts immune responses to vaccines ‌for use in up to ...

SAN DIEGO , CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Options For All, a California-based nonprofit dedicated to inclusive employment, announced ...

BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs ...

Today’s first public beta of iOS 26.3 is likely the last beta we’ll get from Apple before the company takes a holiday break. Understandably then, the release is light on new features and changes. A ...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...